Peter Como Symposium Platform Presentation - Sara Picó

(November 5, 2021) The Peter Como HD Symposium is named in honor and in memory of Dr. Peter Como, a founding member of the Huntington Study Group who played a key role in starting the symposium. The symposium focuses on clinical HD research by presenting valuable findings and information to event attendees through platform presentations of submitted abstracts as selected by the HSG Publications Committee.
Sara Pico is a last-year Ph.D. Student at Center for Molecular Biology “Severo Ochoa” in Madrid. Since her Biochemistry university studies in Seville, she has been interested in molecular biology, so she joined the Molecular Biomedicine Master program at Autonomous University of Madrid in order to start her scientific career working in neurodegenerative diseases at José Lucas’ Lab. There, she started investigating the role of RNA-binding proteins, specifically in Huntington's disease. It was in this way that they discovered a potential therapeutic target for HD, which led Sara to develop skills in analyzing HD patient samples as well as in preclinical studies with HD mouse models. This work has been recently published in Science Translational Medicine (Picó et al., 2021).